Test Overview
Hepatitis B virus (HBV) tests check for substances in the blood
that show whether a
hepatitis B infection is active or has occurred in the
past. The tests look for different signs of infection (markers):
- Antigens are markers made by bacteria or viruses. So
the presence of HBV antigens means that the virus is in the
body.
- Antibodies are proteins produced by the
body to fight infection. The presence of HBV antibodies means that you have
been exposed to the hepatitis B virus at some time. But you could have been
infected long ago and gotten better, or you may have a current
infection.
- Genetic material (DNA) of the
hepatitis B virus shows that the virus is in the body. The amount of DNA can
help determine how severe the infection is and how easily the HBV infection can
be spread.
It is important to identify the type of hepatitis virus causing
infection to prevent its spread and choose the proper treatment.
HBV is transmitted through infected body fluids, including blood,
semen, and vaginal fluids (including menstrual blood).
It also can be transmitted from a pregnant woman to her child at or near the
time of birth.
There are several different HBV tests. These are the HBV tests
most commonly done:
- Hepatitis B surface antigen (HBsAg) is
the earliest indicator of an active hepatitis B infection. This antigen may be
present before symptoms of an HBV infection are present. If this antigen level
remains high for more than 6 months, then you will probably become a carrier of
HBV, meaning you can transmit it to others throughout your
life.
- Hepatitis B surface antibody (HBsAb)
usually appears about 4 weeks after HBsAg disappears. The presence of this
antibody means that the infection is at the end of its active stage and you
cannot pass the virus to others (you are no longer contagious). This antibody
also protects you from getting HBV again in the future. The test is done to
determine the need for vaccination—the antibody will be present after receiving
the HBV vaccine series, showing that you have protection (immunity) from the
virus. Occasionally your test may show that you have both the HBsAb and HBsAg
antibodies. In this case, you are still contagious.
- Hepatitis B e-antigen (HBeAg) is an HBV protein that is only
present during an active HBV infection. This test determines how contagious you
are. Testing for this antigen can also be used to monitor the effectiveness of
treatment for HBV.
- HBV DNA testing checks
for genetic material (DNA) from the hepatitis B virus. The
HBV DNA tests measure how much genetic material is present. A high level of HBV
DNA means that the virus is multiplying in your body and you are very
contagious. If you have a chronic HBV, an elevated viral DNA level means you
are at an increased risk for liver damage and may want to consider treatment
with antiviral medicine. Testing for HBV DNA is also used to monitor the
effectiveness of treatment for chronic HBV infection. HBV DNA testing is a more
sensitive test than HBeAg (above) for detecting HBV in the blood.
Other HBV tests are not done as often:
- Hepatitis B core antibody (HBcAb) is
an antibody to the hepatitis B core antigen that appears about 1 month after an
active HBV infection. It can be found in people who had an infection in the
past and in those with long-term (chronic) HBV. It usually is present for life.
Blood banks test for this antibody when screening donated blood for hepatitis
B.
- Hepatitis B core antibody IgM (HBcAbIgM)
is another antibody to the hepatitis B core antigen. It indicates an HBV
infection that has occurred within the last 6 months.
- Hepatitis B e-antibody (HBeAb) shows that the active stage of
an acute HBV infection is almost over, and your risk of being contagious is
greatly reduced.
A hepatitis B vaccine is available to prevent an HBV
infection.
Hepatitis D virus (HDV) testing
Infection with the hepatitis D virus
(HDV), or delta agent, occurs only in people who are already infected
with the hepatitis B virus (HBV). Vaccination against hepatitis B will prevent
hepatitis D infection. Hepatitis D infection is rare in the United States and
Canada, except among people who inject illegal drugs and those who are
frequently exposed to blood products. The hepatitis D test detects HDV
antibodies. A positive test indicates only that you have been infected with
HDV—it cannot distinguish between an acute or chronic infection. Another test,
the HDV RNA test, is needed to determine whether you have an active HDV
infection. It does not distinguish between an acute or chronic infection. This
test currently is not available except in research settings.
Since hepatitis B infections can be spread through sexual contact,
practice safe sex until your test results are returned.